-
Launch of public consultation on joint network strategy to 2025
Launch of public consultation on joint network strategy to 2025
-
Launch of public consultation on joint network strategy to 2025
Launch of public consultation on joint network strategy to 2025
EMA and the Heads of Medicines Agencies (HMA) have developed a joint strategy for the next five years that is released for a two-month public consultation today.
-
First COVID-19 treatment authorised for use in the EU
First COVID-19 treatment authorised for use in the EU
-
First COVID-19 treatment authorised for use in the EU
First COVID-19 treatment authorised for use in the EU
The European Commission has granted a conditional marketing authorisation for Veklury (remdesivir), for the treatment of COVID-19 in adults and adolescents with pneumonia who require supplemental oxygen.
-
International regulators provide guiding principles for COVID-19 clinical trials
International regulators provide guiding principles for COVID-19 clinical trials
-
International regulators provide guiding principles for COVID-19 clinical trials
International regulators provide guiding principles for COVID-19 clinical trials
EMA has endorsed a joint statement on prioritisation of COVID-19 clinical trials published by the International Coalition of Medicines Regulatory Authorities (ICMRA) committing to step up global collaboration to facilitate and expedite the development and evaluation of therapeutics, diagnostics and vaccines against COVID-19.
-
COVID-19: latest updates
COVID-19: latest updates
-
COVID-19: latest updates
COVID-19: latest updates
Keep up to date with the latest information from EMA on the COVID-19 pandemic.
